Emergency medicine

CENTEGIX® Launches Healthcare Safety Platform™ to Protect Frontline Workers

Retrieved on: 
Wednesday, March 27, 2024
Emergency, American Medical Association, Job satisfaction, Public health, Commissioner, Safety, School, SVP, Hospital, Health care, Magic, Emergency Nurses Association, Baystate Health, Former, Emergency medicine, Tufts Medical Center, American Osteopathic Association, Workplace, Nursing, ENA, Workplace violence, Commonwealth, Violence

ATLANTA, March 27, 2024 /PRNewswire/ -- CENTEGIX, the leading wearable safety technology provider, announces the launch of its CENTEGIX Safety Platform™ for hospitals and health systems, a cloud-based integrated solution designed to initiate the fastest response time to safety incidents across any hospital campus.

Key Points: 
  • Healthcare workers are some of the most threatened in the workplace as violence against healthcare staff continues to rise.
  • "The healthcare workers who protect us are among the most threatened in their workplace," said Brent Cobb, CEO of CENTEGIX.
  • The design of the Safety Platform is based on CENTEGIX's experience supporting frontline workers in various industries, predominantly K-12 educators, who also experience workplace safety concerns.
  • There isn't a magic fix-all for workplace violence in the healthcare setting, but with proactive and multi-layered safety plans, we can make improvements to better protect our healthcare staff.

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device

Retrieved on: 
Tuesday, March 19, 2024
Ready4, Fresenius Medical Care, Learning, Safety, Kidney, Augmented reality, Education, Knowledge, Hospital, Emergency medicine, Augment, Intensive care medicine, Dialysis, FME, BAD, ICU, Nursing, Health, Medtech

The glasses stream visual and acoustic recordings as users interact with the dialysis machine, providing professionals with an immersive learning experience.

Key Points: 
  • The glasses stream visual and acoustic recordings as users interact with the dialysis machine, providing professionals with an immersive learning experience.
  • Our innovative solution is designed to ensure that nursing staff, particularly those in Intensive Care Units, are equipped with the knowledge needed to provide high-quality and exceptional patient care," says Dr. Katarzyna Mazur-Hofsäß, member of the Management Board of Fresenius Medical Care AG and responsible for Care Enablement, Fresenius Medical Care's MedTech segment.
  • The AR glasses provide access to the Augmented Reality learning program Ready4 multiFiltratePRO AR, which Fresenius Medical Care presented today at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels.
  • Ready4 multiFiltratePRO AR has been specifically developed for use with the multiFiltratePRO, Fresenius Medical Care's Continuous Kidney Replacement Therapy system.

Cytovale's Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Retrieved on: 
Tuesday, March 19, 2024
Diagnosis, Sepsis, Conference, Infection, Risk, Patient, SAN, Food and Drug Administration, Hospital, Emergency medicine, Triage, Death, Intensive care medicine, Emergency department, Critical care, ED, Hospice and palliative medicine, Food, FDA, Health, Pharmaceutical industry

The test generates results in about 8 minutes using a standard blood draw, and can be seamlessly and efficiently integrated into existing care workflows.

Key Points: 
  • The test generates results in about 8 minutes using a standard blood draw, and can be seamlessly and efficiently integrated into existing care workflows.
  • Compared to controls, patients whose care was informed by IntelliSep testing spent less time in the hospital and benefited from more efficient triage, resulting in significant cost savings.
  • On average, the study showed that IntelliSep-informed care led to cost savings of:
    Taken together, this study showed an average cost savings of $1,429 per patient across the entire IntelliSep tested cohort.
  • The combination of cost savings for our patients, paired with a faster time to return home to their families, is a game changer."

DO placements in 2024 NRMP Match reach all-time high

Retrieved on: 
Friday, March 15, 2024
Internal medicine, GME, SOAP, Psychiatry, PGY-1, DOS, Rehabilitation, General surgery, Student, MBA, Anesthesiology, Gynaecology, Pediatrics, Emergency medicine, American Osteopathic Association, AOA, Obstetrics, NRMP, Medicine

CHICAGO, March 15, 2024 /PRNewswire/ -- The American Osteopathic Association is pleased to announce that a record high number of 7,705 osteopathic medical students and past DO graduates matched into year 1 (PGY-1) residency positions through the National Resident Matching Program (NRMP). This number reflects a 92.3% match rate for the 8,033 DO seniors who participated, a 0.7% increase from last year.

Key Points: 
  • This number reflects a 92.3% match rate for the 8,033 DO seniors who participated, a 0.7% increase from last year.
  • According to NRMP, the match rate for fourth-year osteopathic medical students has increased by 4.2 percentage points since 2019.
  • In total, the 2024 NRMP match included 6,395 certified programs offering 41,503 PGY-1 and PGY-2 training positions, the largest number in the NRMP's 72-year history.
  • The following breakdown shows the top 15 specialties matched into by fourth-year osteopathic medical students seeking PGY-1 placements:

Kaiser Permanente Bernard J. Tyson School of Medicine Announces Residency Placements of Inaugural Medical School Class

Retrieved on: 
Friday, March 15, 2024
Health, Internal medicine, Patient, Family medicine, Emergency medicine, University of Washington, University, Doctor of Philosophy, Faculty, MD, Student, Curriculum, Workforce, Kaiser Permanente, Work, Physician, HSS, Pediatrics, Nursing

PASADENA, Calif., March 15, 2024 /PRNewswire/ -- The Kaiser Permanente Bernard J. Tyson School of Medicine (KPSOM) celebrated its first annual Match Day, a milestone event for the new medical school and its inaugural class of students. On Match Day, medical students learn where they will begin their careers as physicians.

Key Points: 
  • PASADENA, Calif., March 15, 2024 /PRNewswire/ -- The Kaiser Permanente Bernard J. Tyson School of Medicine (KPSOM) celebrated its first annual Match Day, a milestone event for the new medical school and its inaugural class of students.
  • "KPSOM's inaugural class is a group of passionate, caring and creative students whose years of hard work have now led them to the threshold of residency," said Mark Schuster, MD, PhD, founding dean and chief executive officer of the Kaiser Permanente Bernard J. Tyson School of Medicine.
  • Internal Medicine, Emergency Medicine, and Family Medicine are the top three most matched specialty programs, and 38% are matched into primary care specialties, including Family Medicine, Internal Medicine, and Pediatrics.
  • "It has been an honor to support and watch this class grow, learn and thrive over the last four years," said Anne Eacker, MD, senior associate dean for student affairs at Kaiser Permanente Bernard J. Tyson School of Medicine.

NRMP® Celebrates Match Day for the 2024 Main Residency Match®, Releases Results for Over 44,000 Applicants and Almost 6,400 Residency Programs

Retrieved on: 
Friday, March 15, 2024
Interventional radiology, PGY-1, Internal medicine, Growth, Pathology, Med-Peds, COVID-19, Anne Ferguson-Smith, Internal, Emergency medicine, MD, MBA, Competition (economics), Cardiothoracic surgery, Orthopedic surgery, BSN, Acceptance, Workforce, Physician, Doctor of Health Science, NRMP, Nursing

This year's Match included 44,853 applicants who certified a rank order list ("active applicants") and 41,503 certified positions in 6,395 residency training programs.

Key Points: 
  • This year's Match included 44,853 applicants who certified a rank order list ("active applicants") and 41,503 certified positions in 6,395 residency training programs.
  • A total of 50,413 applicants registered in the 2024 Main Residency Match, an all-time high and increase of 2,257 or 4.7 percent over last year.
  • Increases afforded applicants access to 125 more programs and 1,128 positions which is 2.8 percent more than the 2023 Main Residency Match.
  • Detailed SOAP results will be available in the 2024 Main Residency Match Results and Data Book, which is published in the Spring.

Burrell College of Osteopathic Medicine Student Wins the SignatureCare Emergency Center 2024 Spring Semester Medical and Health Scholarship

Retrieved on: 
Thursday, March 14, 2024
Diagnosis, Culture, Patient, School, Emergency medicine, MD, Onion, Student, Ancheta, Dream, Language, Adenocarcinoma, Book, Family, Parent, Doctorate, Medicine, Nursing

HOUSTON, March 14, 2024 /PRNewswire-PRWeb/ -- The SignatureCare Emergency Center Scholarship Award Committee is pleased to announce that it has selected Anamaria Ancheta, a Burrell College of Osteopathic Medicine, New Mexico, Doctorate of Osteopathic Medicine (DO) student as the 2024 Spring Semester Medical and Health Scholarship winner.

Key Points: 
  • Anamaria Ancheta said her passion for medicine was sparked by her grandfather's Cancer diagnosis and the desire to help the Hispanic community in the U.S.
    HOUSTON, March 14, 2024 /PRNewswire-PRWeb/ -- The SignatureCare Emergency Center Scholarship Award Committee is pleased to announce that it has selected Anamaria Ancheta, a Burrell College of Osteopathic Medicine, New Mexico , Doctorate of Osteopathic Medicine (DO) student as the 2024 Spring Semester Medical and Health Scholarship winner.
  • While accepting the award, Anamaria Ancheta said receiving this scholarship will help ease the burden of her college tuition.
  • Dr. Christopher Langan, MD, an Emergency Medicine Physician and Chief Operating Officer (COO) of SignatureCare Emergency Center, congratulated Ms. Ancheta for winning the award.
  • On behalf of everyone at SignatureCare Emergency Center, I congratulate her for winning this scholarship award," he said.

ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors

Retrieved on: 
Wednesday, March 6, 2024
Translational medicine, SAN, MD, Emergency medicine, Partnership, Atopic dermatitis, Asthma, Chronic obstructive pulmonary disease, Rutgers University, Formoterol, Associate, Patient, Disease, Constriction, Harvard Medical School, ASLN, Pharmaceutical industry

“I’m delighted to work with the ASLAN team on this exciting opportunity to evaluate development paths for eblasakimab in COPD, a Type 2-driven disease.

Key Points: 
  • “I’m delighted to work with the ASLAN team on this exciting opportunity to evaluate development paths for eblasakimab in COPD, a Type 2-driven disease.
  • In November 2023, ASLAN announced translational data from healthy donor tissue that suggested eblasakimab’s potential as a COPD therapeutic to inhibit Type 2 inflammation.
  • Further studies have been conducted using lung tissue from a COPD patient, comparing the same concentrations of eblasakimab and dupilumab.
  • Further translational data on eblasakimab in COPD will be submitted for publication at upcoming scientific congresses.

Study Surmounts Barrier to Measuring Healthcare Worker Exposure to Workplace Violence

Retrieved on: 
Tuesday, February 27, 2024
School, Incidence, Anxiety, Hospital, Violence, Doctor of Philosophy, Military, Health, MD, Emergency medicine, Research, Workplace violence, Quality, Foot, FAAN, WPV, Aggression, Outline of health sciences, Safety, Joint Commission, APRN, Patient safety, Emergency, Organization, Journal, Yale University, Psychiatry, FACEP, Editorial, Depression, Nursing

OAKBROOK TERRACE, Illinois, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Workplace violence (WPV), including physical assaults and verbal threats, is a pervasive and significant issue for healthcare workers and organizations.

Key Points: 
  • OAKBROOK TERRACE, Illinois, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Workplace violence (WPV), including physical assaults and verbal threats, is a pervasive and significant issue for healthcare workers and organizations.
  • WPV directly harms healthcare workers and increases their anxiety, depression and staff turnover.
  • Rates of WPV are likely underestimated because past studies have mostly used surveys that rely on recall of past events.
  • A study featured in the March 2024 issue of The Joint Commission Journal on Quality and Patient Safety (JQPS) overcomes this important barrier by precisely measuring nurse and patient care assistant exposure rates to patient aggression in real time, shedding light on prevention and management measures.

ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities

Retrieved on: 
Tuesday, March 5, 2024
Biotechnology, FDA, AIDS, Health, Training, Pharmaceutical, Other Education, Other Philanthropy, Philanthropy, Research, Infectious Diseases, Education, Science, Clinical Trials, Acquisition, Pre-exposure prophylaxis, Pfizer, Incidence, Shionogi, Woman, Medicine, Fungal infection, GSK, CROI, HIV Medicine, Notifiable disease, Emergency medicine, Dawn, Conference, Gynaecology, Mentorship, Preceptor, Patient, MPH, ViiV Healthcare, HIV, Obstetrics, American Academy, Pharmaceutical industry

Today, ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the American Academy of HIV Medicine (AAHIVM) jointly announced the launch of The Dr.

Key Points: 
  • Today, ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the American Academy of HIV Medicine (AAHIVM) jointly announced the launch of The Dr.
  • Dawn K. Smith HIV Prevention Clinical Fellowship.
  • The fellowship will provide comprehensive HIV training to non-infectious disease clinicians serving communities disproportionately affected by HIV.
  • Dawn K. Smith HIV Prevention Clinical Fellowship, experienced HIV clinicians will provide that training in priority populations and areas, with a special emphasis on pre-exposure prophylaxis (PrEP).”
    The Dr.